11-7565759-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000299492.9(PPFIBP2):c.271G>A(p.Glu91Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000211 in 1,614,114 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000299492.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PPFIBP2 | NM_003621.5 | c.271G>A | p.Glu91Lys | missense_variant | 3/24 | ENST00000299492.9 | NP_003612.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PPFIBP2 | ENST00000299492.9 | c.271G>A | p.Glu91Lys | missense_variant | 3/24 | 1 | NM_003621.5 | ENSP00000299492 | P2 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152194Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000956 AC: 24AN: 251158Hom.: 0 AF XY: 0.0000810 AC XY: 11AN XY: 135754
GnomAD4 exome AF: 0.0000219 AC: 32AN: 1461802Hom.: 0 Cov.: 32 AF XY: 0.0000179 AC XY: 13AN XY: 727200
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152312Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74478
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 27, 2022 | The c.271G>A (p.E91K) alteration is located in exon 3 (coding exon 2) of the PPFIBP2 gene. This alteration results from a G to A substitution at nucleotide position 271, causing the glutamic acid (E) at amino acid position 91 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at